REFERENCES
- Centre For Disease Control, USA (1978). Chloroquine resistant malaria acquired in Kenya and Tanzania. Morbidity and Mortality Weekly Report, 27, 463–464.
- Eichenlaub, D., Rögler, G., Hoffman, H. G. & Weise, H. J. (1982). Falciparum malaria despite pyrimethamine/sulfadoxine prophylaxis in five tourists to East Africa. Lancet, ii, 1041–1042.
- Kihamia, C. M. & Gill, H. S. (1982). Chloroquine-resistant falciparum malaria in semi-immune native African Tanzanians. Lancet, ii, 43.
- Koch-Weser, J., Hodel, C., Leimer, R. & Styk, S. (1982). Adverse reactions to pyrimethamine/sulphadoxine. Lancet, ii, 1459
- Lelijveld, J. & Mzoo, F. (1970). The effects af small single doses of chloroquine on Plasmodium falciparum infections in North eastern Tanzania. Bulletin of the World Health Organization, 42, 471–477.
- Onori, E., Payne, D., Grab, B., Horst, H. I., Almeida Franco, J. & Joia, H. (1982). Incipient resistance to Plasmodium falciparum to chloroquine among a semi-immune population of the United Republic of Tanzania. Bulletin of the World Health Organization, 60, 77–87.
- Timmermanns, P. M., Hess, U. & Jones, M. E. (1982). Pyrimethamine/sulfadoxine resistant Falciparum malaria in East Africa. Lancet, i, 1181.
- World Health Organization (1973). WHO Technical Report Series, No. 529, 32–37.
- Wilson, T. & Edeson, J. F. B. (1954). Studies on the chemotherapy of malaria. III. The treatment of acute malaria with chloroquine. Medical Journal of Malaya, 9, 115–133.